Not applicableActive Not RecruitingNCT03426748What this trial is testingLDR vs. HDR Brachytherapy for Prostate CancerWho this might be right forProstate Cancer British Columbia Cancer Agency 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT05498272What this trial is testingStudy of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsWho this might be right forProstate CancerBRCA1 MutationBRCA2 Mutation+2 more Rana McKay, MD 32
Not applicableActive Not RecruitingNCT02339701What this trial is testingStereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate CancerWho this might be right forProstate Cancer Chinese University of Hong Kong 68
Large-scale testing (Phase 3)WithdrawnNCT04225299What this trial is testingEvaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerWho this might be right forLocalized Prostate Cancer Steba Biotech S.A.
Not applicableEnded earlyNCT02478112What this trial is testingUse of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)Who this might be right forProstate Cancer Centre Oscar Lambret 24
Not applicableLooking for participantsNCT05438563What this trial is testingMRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate CancerWho this might be right forProstate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8 Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT00888654What this trial is testingDiindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical ProstatectomyWho this might be right forProstate Cancer Barbara Ann Karmanos Cancer Institute 41
Not applicableStudy completedNCT01542021What this trial is testingAndrogen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerWho this might be right forProstate CancerProstatic Adenocarcinoma Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00003104What this trial is testingComputer Planned Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT04984343What this trial is testingRandomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate CancerWho this might be right forProstate Cancer Weill Medical College of Cornell University 33
Large-scale testing (Phase 3)Study completedNCT00067015What this trial is testingRadiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06835725What this trial is testingPhase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate CancerWho this might be right forProstate CA British Columbia Cancer Agency 100
Not applicableWithdrawnNCT00963300What this trial is testingMRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation TherapyWho this might be right forProstate Cancer University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07393867What this trial is testingAndrogen-responsive POSLUMA-guided Intra-prostatic BoostWho this might be right forIntermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer Martin T. King, MD, PhD 23
Not applicableStudy completedNCT01379872What this trial is testingAssessment of New Radiation Oncology Technologies and TreatmentsWho this might be right forProstate Cancer (Post Prostatectomy)Anal CancerNasopharyngeal Cancer+1 more Trans Tasman Radiation Oncology Group 138
Early research (Phase 1)Looking for participantsNCT05864196What this trial is testingTwo Fraction Prostate SBRT With DIL SIBWho this might be right forProstate Cancer NYU Langone Health 80
Testing effectiveness (Phase 2)Study completedNCT03315754What this trial is testingStudy of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.Who this might be right forLocalized Prostate Cancer Steba Biotech S.A. 50
Not applicableUnknownNCT02895854What this trial is testingLDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer PatientsWho this might be right forProstate Cancer Kuopio University Hospital 44
Not applicableEnded earlyNCT01737151What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate Cancer Virginia Commonwealth University 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04465500What this trial is testingEBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate CancerWho this might be right forProstate CancerProstate Adenocarcinoma University of Virginia 60